loadpatents
name:-0.11369395256042
name:-0.036896944046021
name:-0.0021698474884033
Celis; Esteban Patent Filings

Celis; Esteban

Patent Applications and Registrations

Patent applications and USPTO patent grants for Celis; Esteban.The latest application filed is for "human alpha fetoprotein-specific t cell receptors and uses thereof".

Company Profile
1.21.44
  • Celis; Esteban - Augusta GA
  • Celis; Esteban - Tampa FL
  • Celis; Esteban - Rochester MN
  • Celis, Esteban - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Human Alpha Fetoprotein-specific T Cell Receptors And Uses Thereof
App 20220048971 - He; Yukai ;   et al.
2022-02-17
Human alpha fetoprotein-specific murine T cell receptors and uses thereof
Grant 11,041,011 - He , et al. June 22, 2
2021-06-22
Method of developing a vaccine using peptide-poly IC complexes
Grant 10,463,747 - Celis No
2019-11-05
Human Alpha Fetoprotein-Specific Murine T Cell Receptors and Uses Thereof
App 20180327473 - He; Yukai ;   et al.
2018-11-15
Method Of Developing A Vaccine Using Peptide-poly Ic Complexes
App 20180055945 - Celis; Esteban
2018-03-01
Method of developing a vaccine using peptide-poly IC complexes
Grant 9,770,513 - Celis September 26, 2
2017-09-26
Inducing Cellular Immune Responses to Plasmodium Falciparum Using Peptide and Nucleic Acid Compositions
App 20160193316 - Sette; Alessandro ;   et al.
2016-07-07
HLA binding motifs and peptides and their uses
Grant 9,340,577 - Grey , et al. May 17, 2
2016-05-17
Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions
Grant 9,266,930 - Sette , et al. February 23, 2
2016-02-23
Chimeric antigen-specific T cell-activating polypeptides
Grant 8,822,182 - Celis September 2, 2
2014-09-02
Hla Class I A2 Tumor Associated Antigen Peptides And Vaccine Compositions
App 20140147490 - Fikes; John D. ;   et al.
2014-05-29
Method Of Developing A Vaccine Using Peptide-poly Ic Complexes
App 20140112943 - Celis; Esteban
2014-04-24
Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid Compositions
App 20130017253 - SETTE; Alessandro ;   et al.
2013-01-17
HPV 16 peptide vaccine for head and neck cancer
Grant 8,263,560 - Strome , et al. September 11, 2
2012-09-11
Hla Class I A2 Tumor Associated Antigen Peptides And Vaccine Compositions
App 20110318408 - Fikes; John D. ;   et al.
2011-12-29
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
App 20110097352 - Sette; Alessandro ;   et al.
2011-04-28
Mage-a3/hpv 16 Peptide Vaccines For Head And Neck Cancer
App 20110070252 - Strome; Scott E. ;   et al.
2011-03-24
Chimeric Antigen-specific T Cell-activating Polypeptides
App 20110071273 - CELIS; ESTEBAN
2011-03-24
Chimeric antigen-specific t cell-activating polypeptides
Grant 7,842,480 - Celis November 30, 2
2010-11-30
Methods and materials for cancer treatment
Grant 7,795,381 - Celis September 14, 2
2010-09-14
Mage-a3/hpv 16 Peptide Vaccines For Head And Neck Cancer
App 20100183646 - STROME; Scott E. ;   et al.
2010-07-22
Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid Compositions
App 20100068228 - SETTE; Alessandro ;   et al.
2010-03-18
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
App 20090311283 - Sette; Alessandro ;   et al.
2009-12-17
Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions
App 20090304746 - Sette; Alessandro ;   et al.
2009-12-10
Inducing cellular immune responses to hepatitis B virus using peptide compositions
Grant 7,611,713 - Sette , et al. November 3, 2
2009-11-03
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
App 20090214632 - Sette; Alessandro ;   et al.
2009-08-27
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
Grant 7,572,882 - Sette , et al. August 11, 2
2009-08-11
HLA binding peptides and their uses
App 20090012004 - Sette; Alessandro ;   et al.
2009-01-08
HLA class I A2 tumor associated antigen peptides and vaccine compositions
App 20080279924 - Fikes; John D. ;   et al.
2008-11-13
HLA binding motifs and peptides and their uses
App 20080260762 - Grey; Howard M. ;   et al.
2008-10-23
Epstein-barr-virus-specific immunization
Grant 7,422,751 - Celis September 9, 2
2008-09-09
Methods And Materials For Cancer Treatment
App 20080119636 - Celis; Esteban
2008-05-22
Mage-a3/hpv 16 Peptide Vaccines For Head And Neck Cancer
App 20080044407 - Strome; Scott E. ;   et al.
2008-02-21
HLA binding peptides and their uses
Grant 7,252,829 - Sette , et al. August 7, 2
2007-08-07
HLA class I A2 tumor associated antigen peptides and vaccine compositions
App 20070098776 - Fikes; John D. ;   et al.
2007-05-03
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
App 20070059799 - Sette; Alessandro ;   et al.
2007-03-15
HLA binding motifs and peptides and their uses
App 20070055049 - Grey; Howard M. ;   et al.
2007-03-08
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
App 20070053922 - Sette; Alessandro ;   et al.
2007-03-08
Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions
App 20070020327 - Fikes; John ;   et al.
2007-01-25
Epstein-barr virus-specific immunization
App 20060257356 - Celis; Esteban
2006-11-16
MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
App 20060222656 - Strome; Scott E. ;   et al.
2006-10-05
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
Grant 7,026,443 - Sette , et al. April 11, 2
2006-04-11
Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
App 20050271676 - Sette, Alessandro ;   et al.
2005-12-08
Inducing cellular immune responses to p53 using peptide and nucleic acid compositions
App 20050196403 - Fikes, John ;   et al.
2005-09-08
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
App 20050063983 - Sette, Alessandro ;   et al.
2005-03-24
Chimeric antigen-specific t cell-activating polypeptides
App 20040249126 - Celis, Esteban
2004-12-09
Methods and materials for cancer treatment
App 20040202654 - Celis, Esteban
2004-10-14
Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions
App 20040146519 - Fikes, John ;   et al.
2004-07-29
Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions
App 20040121946 - Fikes, John ;   et al.
2004-06-24
Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositions
App 20040053822 - Fikes, John ;   et al.
2004-03-18
Inducing cellular immune responses to p53 using peptide and nucleic acid compositions
App 20040048790 - Fikes, John ;   et al.
2004-03-11
Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions
App 20040037843 - Fikes, John ;   et al.
2004-02-26
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
Grant 6,689,363 - Sette , et al. February 10, 2
2004-02-10
Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions
App 20040018971 - Fikes, John ;   et al.
2004-01-29
Hla class I a2 tumor associated antigen peptides and vaccine compositions
App 20030224036 - Fikes, John D ;   et al.
2003-12-04
HLA class I A2 tumor associated antigen peptides and vaccine compositions
Grant 6,602,510 - Fikes , et al. August 5, 2
2003-08-05
Compositions and methods for eliciting CTL immunity
App 20030099634 - Vitiello, Maria A. ;   et al.
2003-05-29
Hla Binding Peptides And Their Uses
App 20020168374 - KUBO, RALPH T. ;   et al.
2002-11-14
Methods for making HLA binding peptides and their uses
Grant 6,037,135 - Kubo , et al. March 14, 2
2000-03-14
Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes
Grant 5,662,907 - Kubo , et al. September 2, 1
1997-09-02
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed